These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30292353)

  • 1. Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors.
    Gibbs ZA; Whitehurst AW
    Trends Cancer; 2018 Oct; 4(10):701-712. PubMed ID: 30292353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Splicing and Cancer.
    Wang E; Aifantis I
    Trends Cancer; 2020 Aug; 6(8):631-644. PubMed ID: 32434734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
    Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
    Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer/testis (CT) antigens: potential targets for immunotherapy.
    Caballero OL; Chen YT
    Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients.
    Parmigiani RB; Bettoni F; Vibranovski MD; Lopes MH; Martins WK; Cunha IW; Soares FA; Simpson AJ; de Souza SJ; Camargo AA
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18066-71. PubMed ID: 17114284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Cancer-Testis Antigens in Pediatric Cancers.
    Ghafouri-Fard S
    Asian Pac J Cancer Prev; 2015; 16(13):5149-52. PubMed ID: 26225644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF; Burns J; Ditzel HJ
    Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
    Yang P; Huo Z; Liao H; Zhou Q
    Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
    Bodey B
    Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer/testis antigens, gametogenesis and cancer.
    Simpson AJ; Caballero OL; Jungbluth A; Chen YT; Old LJ
    Nat Rev Cancer; 2005 Aug; 5(8):615-25. PubMed ID: 16034368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and functional aspects of MAGEA3 cancer/testis antigen.
    Das B; Senapati S
    Adv Protein Chem Struct Biol; 2021; 125():121-147. PubMed ID: 33931137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.
    Siliņa K; Zayakin P; Kalniņa Z; Ivanova L; Meistere I; Endzeliņš E; Abols A; Stengrēvics A; Leja M; Ducena K; Kozirovskis V; Linē A
    J Immunother; 2011 Jan; 34(1):28-44. PubMed ID: 21150711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.
    Akers SN; Odunsi K; Karpf AR
    Future Oncol; 2010 May; 6(5):717-32. PubMed ID: 20465387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer.
    Maxfield KE; Taus PJ; Corcoran K; Wooten J; Macion J; Zhou Y; Borromeo M; Kollipara RK; Yan J; Xie Y; Xie XJ; Whitehurst AW
    Nat Commun; 2015 Nov; 6():8840. PubMed ID: 26567849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer/testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironment.
    Wang Y; Song X; Zheng Y; Liu Z; Li Y; Qian X; Pang X; Zhang Y; Yin Y
    Int J Med Sci; 2018; 15(14):1702-1712. PubMed ID: 30588194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.
    Almeida LG; Sakabe NJ; deOliveira AR; Silva MC; Mundstein AS; Cohen T; Chen YT; Chua R; Gurung S; Gnjatic S; Jungbluth AA; Caballero OL; Bairoch A; Kiesler E; White SL; Simpson AJ; Old LJ; Camargo AA; Vasconcelos AT
    Nucleic Acids Res; 2009 Jan; 37(Database issue):D816-9. PubMed ID: 18838390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer-testis antigens in stem cells: is it a potential drawback or an advantage in cancer immunotherapy.
    Ghafouri-Fard S
    Asian Pac J Cancer Prev; 2015; 16(7):3079-81. PubMed ID: 25854409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cause and consequence of cancer/testis antigen activation in cancer.
    Whitehurst AW
    Annu Rev Pharmacol Toxicol; 2014; 54():251-72. PubMed ID: 24160706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.